Cargando…
Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19
Pentoxifylline (PTX) is a phosphodiesterase inhibitor that increases cyclic adenosine monophosphate levels, which in turn activate protein kinase, leading to a reduction in the synthesis of proinflammatory cytokines to ultimately influence the renin-angiotensin system (RAS) in vitro by inhibiting an...
Autores principales: | Maldonado, Valente, Loza-Mejía, Marco A., Chávez-Alderete, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282759/ https://www.ncbi.nlm.nih.gov/pubmed/32540603 http://dx.doi.org/10.1016/j.mehy.2020.109988 |
Ejemplares similares
-
Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study
por: Maldonado, Valente, et al.
Publicado: (2021) -
Renin–Angiotensin–Aldosterone System and Immunomodulation: A State-of-the-Art Review
por: Laghlam, Driss, et al.
Publicado: (2021) -
Pentoxifylline immunomodulation in the treatment of experimental chronic pulmonary paracoccidioidomycosis
por: Lopera, Damaris Elena, et al.
Publicado: (2015) -
What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004) -
Regulation of Male Fertility by the Renin-Angiotensin System
por: Gianzo, Marta, et al.
Publicado: (2020)